Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ginkgo

Cathie Wood snaps up 130,000 shares of plummeting, $1 stock

Ark Invest is continuing to snag shares of a biotech firm’s declining stock.

Cathie Wood sinks hundreds of thousands into a super-cheap tech stock (again)

Cathie Wood sinks hundreds of thousands into a super-cheap tech stock (again)

The Ark Invest CEO also sold off millions of her favorite stock to invest in this one.

Cathie Wood just bought 6 million shares of biotech firm

Cathie Wood just bought 6 million shares of biotech firm

Ark Invest really likes this technology stock.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Cathie Wood Dives Deeper Into Two Big Biotech Stocks

Ark Invest loves its tech stocks.

Cathie Wood Buys Millions of Shares of a Struggling Stock

Ark Invest is embracing biotechnology.

Is Ginkgo Bioworks Putting Its $1.5 Billion Cash Hoard to Good Use?

The synthetic biology leader's healthy cash balance provides plenty of breathing room, but it won't last forever.

Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity milestone in their par

inkl

Read news from The Economist, FT, and more,
with one subscription

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study

The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

New 'hidden courtyard' to open along Stockport's Underbanks

New 'hidden courtyard' to open along Stockport's Underbanks

"We want the yard to be an escape for visitors, where they can get a few minutes of headspace in a tranquil spot"

Manchester Evening News

Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock

Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock

Ark Investment Management, led by Tesla Inc.

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm

Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm

Elanco Animal Health Incorporated (NYSE:ELAN) and Ginkgo Bioworks Holdings Inc (NYSE:DNA) have launched BiomEdit, a microbiome innovation company. BiomEdit will discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines, and microbial monitoring services for animal health. In October last year, Elanco announced its intention to carve out its microbiome platform and pipeline under the leadership…

Here's Why Ginkgo Bioworks Shares Are Rising

Here's Why Ginkgo Bioworks Shares Are Rising

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 22.0% at $4.56 after the company reported better-than-expected fourth-quarter sales results and issued FY22 sales guidance above analyst estimates.

Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street Expectations

Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street Expectations

Ginkgo Bioworks Holdings Inc (NYSE: DNA) reported

Ginkgo Bioworks Adds Ultra-High-Throughput Screening Platform Via FGen Acquisition

Ginkgo Bioworks Adds Ultra-High-Throughput Screening Platform Via FGen Acquisition

Ginkgo Bioworks Holdings Inc (NYSE: DNA) has

Get all your
news in one place.

100’s of premium titles.
One news app.

Ginkgo Bioworks Announces Acquisition Of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC; Terms Not Disclosed

Acquisition to enable Ginkgo to bolster its growing biosecurity platform and provide expanded COVID-19 testing options to communities in Massachusetts and beyond

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Ark Investment Management

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

245,148 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play